[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] # Dyne Therapeutics, Inc. Common Stock (DYN) Dyne Therapeutics announces positive topline results from its Phase 1/2 DELIVER trial for z-rostudirsen in Duchenne muscular dystrophy, potentially offering a more effective alternative to current therapies. The company plans to file for approval, with analysts raising price targets. ### About Dyne Therapeutics, Inc. Common Stock Dyne Therapeutics, Inc. is a biotechnology company focused on developing therapies for neuromuscular disorders. Dyne Therapeutics, Inc. Common Stock uses the ticker $DYN for trading. Listed in the [Stocks](/list/stocks) category within the [Healthcare](/list/stocks/healthcare) sectors. ### Insights - Dyne Therapeutics, Inc. Common Stock (DYN) social dominance hit XXXXXX which is XXX% higher than it's daily average. - Dyne Therapeutics, Inc. Common Stock (DYN) engagements hit 36.3K which is XXX% higher than it's daily average. - Dyne Therapeutics, Inc. Common Stock (DYN) trading volume is up XXXXXX% from the previous week. - Dyne Therapeutics, Inc. Common Stock (DYN) social dominance is up XXXXXX% from the previous week. - Dyne Therapeutics, Inc. Common Stock (DYN) engagements is up XXXXXX% from the previous week. - Dyne Therapeutics, Inc. Common Stock (DYN) posts created is up XXXXXX% from the previous week. ### Price: $XXXXX  [Price 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/close.tsv) The stock price is currently influenced by positive clinical trial data and FDA designations, but tempered by valuation concerns, leading to a recent pullback after gains. Social media indicates mixed sentiment with analyst target raises and institutional interest. 24-Hour: -XXXXX% 7-Day: -XXXXX% 30-Day: -XXXX% 1-Year High: $XXXXX on 2024-12-11 1-Year Low: $XXXX on 2025-04-08 ### AltRank: XXX  [AltRank 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/alt_rank.tsv) Dyne Therapeutics, Inc. Common Stock (DYN) is currently AltRank #150 based on combined combined social and market metrics Daily Average: XXX X Week: XXX -XXX X Month: XXX -XXX X Months: XXX -XXX X Year: XXX -XXX 1-Year High: XXXXX on 2025-09-15 1-Year Low: X on 2024-12-28 ### Galaxy Score: XXXXX  [Galaxy Score 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/galaxy_score.tsv) Current Value: XXXXX Daily Average: XX X Week: XX -X X Month: XX -X X Months: XX -X X Year: XX -XX 1-Year High: XX on 2025-12-08 1-Year Low: XX on 2025-12-03 ### Engagements: XXXXXX (24h)  [Engagements 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/interactions.tsv) Current Value: XXXXXX Daily Average: XXXXX X Week: XXXXXX +432% X Month: XXXXXXX +23% X Months: XXXXXXXXX -XX% X Year: XXXXXXXXX -XX% 1-Year High: XXXXXXX on 2025-04-25 1-Year Low: XXX on 2025-12-06 Engagements by network (24h): Reddit: XX X: XXXXXX YouTube: XX ### Mentions: XXX (24h)  [Mentions 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/posts_active.tsv) Current Value: XXX Daily Average: XXX X Week: XXX -XX% X Month: XXX -XX% X Months: XXXXX +8.30% X Year: XXXXX +5.70% 1-Year High: XXX on 2025-10-27 1-Year Low: X on 2025-09-14 Mentions by network (24h): Reddit: X X: XXXXX YouTube: X ### Creators: XX (24h)  [Creators 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/contributors_active.tsv) XX unique social accounts have posts mentioning Dyne Therapeutics, Inc. Common Stock (DYN) in the last XX hours which is down XX% from XX in the previous XX hours Daily Average: XX X Week: XXX -XX% X Month: XXX -XX% X Months: XXXXX +120% X Year: XXXXX +74% 1-Year High: XXX on 2025-06-28 1-Year Low: X on 2025-09-14 The most influential creators that mention Dyne Therapeutics, Inc. Common Stock in the last XX hours | Creator | Rank | Followers | Posts | Engagements | | ------- | ---- | --------- | ----- | ----------- | | [@adamfeuerstein](/creator/twitter/adamfeuerstein) | X | XXXXXXX | X | XXXXXX | | [@BioStocks](/creator/twitter/BioStocks) | X | XXXXXX | X | XXXXX | | [@semodough](/creator/twitter/semodough) | X | XXXXXX | X | XXXXX | | [@RNAiAnalyst](/creator/twitter/RNAiAnalyst) | X | XXXXXX | XX | XXXXX | | [@monaco_biotech](/creator/twitter/monaco_biotech) | X | XXXXX | X | XXX | | [@FrenzyCapital](/creator/twitter/FrenzyCapital) | X | XXXXX | XX | XXX | | [@Hall8Jack](/creator/twitter/Hall8Jack) | X | XXXXX | X | XXX | | [@bioinvestor24](/creator/twitter/bioinvestor24) | X | XXXXX | X | XXX | | [@OzmosiHealth](/creator/twitter/OzmosiHealth) | X | XXXXX | X | XXX | | [@BiotechAnalysst](/creator/twitter/BiotechAnalysst) | XX | XXXXX | X | XXX | [View More](/list/creators/dyne-therapeutics/100) ### Sentiment: XX%  [Sentiment 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/sentiment.tsv) Current Value: XX% Daily Average: XX% X Week: XX% -XX% X Month: XX% +13% X Months: XX% +8% X Year: XX% -X% 1-Year High: XXX% on 2025-10-18 1-Year Low: XX% on 2025-01-04 Most Supportive Themes: - Positive Clinical Data and FDA Designation: (40%) Dyne Therapeutics' ACHIEVE trial for DM1 and FDA breakthrough designations are driving positive sentiment. - Favorable Analyst Ratings: (30%) Analyst ratings and price targets, with a consensus of Strong Buy and potential upside, are supporting the stock. - Institutional Ownership: (30%) High institutional ownership and confidence from major funds are contributing to a positive outlook. Most Critical Themes: - Valuation Concerns: (100%) Downgrades from some analysts and concerns about valuation are creating caution despite promising clinical data. ### Social Dominance: XXXXX%  [Social Dominance 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/social_dominance.tsv) Current Value: XXXXX% Daily Average: XXXXX% X Week: XXXXX% +0.047% X Month: XXXXX% +0.042% X Months: XXXXX% +0.035% X Year: XXXXX% +0.0064% 1-Year High: XXXXX% on 2025-04-29 1-Year Low: XXXXXX% on 2025-09-14 ### Market Dominance: XXXXXXX%  [Market Dominance 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/market_dominance.tsv) Current Value: XXXXXXX% Daily Average: X% 1-Year High: XXXXX% on 2025-11-24 1-Year Low: XXXXXXX% on 2025-03-14 ### Market Cap: $XXXXXXXXXXXXX  [Market Cap 24-Hour Time-Series Raw Data](/topic/dyne-therapeutics/time-series/market_cap.tsv) Current Value: $XXXXXXXXXXXXX Daily Average: $XXXXXXXXXXXXX X Week: $XXXXXXXXXXXXX -$10% X Month: $XXXXXXXXXXXXX +$0.76% X Months: $XXXXXXXXXXXXX +$61% X Year: $XXXXXXXXXXXXX -$9.40% 1-Year High: $XXXXXXXXXXXXX on 2025-10-28 1-Year Low: $XXXXXXXXXXX on 2025-04-08 ### Top Dyne Therapeutics, Inc. Common Stock Social Posts Top posts by engagements in the last XX hours *Showing only X posts for non-authenticated requests. Use your API key in requests for full results.* "#Biotech offerings priced - $TERN $650M at $40/share $GPCR $650M at $65/ADS $KYMR $602M at $86/share $WVE $350M at $19/share $DYN $350M at $18.44/share $VERA $261M at $42.50/share $XXXX Billionš„ $XBI" [X Link](https://x.com/BioStocks/status/1998615636621279382) [@BioStocks](/creator/x/BioStocks) 2025-12-10T04:47Z 70.4K followers, 5063 engagements "$DYN Dyne Therapeutics presented P1 Muscular Dystrophy Duchenne results on 2025-12-08 for Zeleciment rostudirsen More Info:" [X Link](https://x.com/OzmosiHealth/status/1998503198491918364) [@OzmosiHealth](/creator/x/OzmosiHealth) 2025-12-09T21:21Z 3011 followers, XXX engagements "Midday Fly By: Nvidia can ship H200s to China Campbell's reports Q1 beat $FERG $VIK $NCLH $CL $VRT $SNPS $SLM $DIS $BAC $C $APO $PSKY $WBD $ACN $CWAN $CPNG $ALEX $TROX $STAA $AA $PHR $CNM $DBI $LE $GIII $DYN $NVDA $HD $CVS $F $RNLSY $RNSDF $CPB" [X Link](https://x.com/theflynews/status/1998451893110997190) [@theflynews](/creator/x/theflynews) 2025-12-09T17:57Z 28.8K followers, XXX engagements "Biggest Losers: $FERG $BEKE $SMMT $KYMR $SLM $GPK $KTB $WRD $AAP $DYN $OLMA" [X Link](https://x.com/FrenzyCapital/status/1998422512296755396) [@FrenzyCapital](/creator/x/FrenzyCapital) 2025-12-09T16:00Z 1563 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Dyne Therapeutics announces positive topline results from its Phase 1/2 DELIVER trial for z-rostudirsen in Duchenne muscular dystrophy, potentially offering a more effective alternative to current therapies. The company plans to file for approval, with analysts raising price targets.
Dyne Therapeutics, Inc. is a biotechnology company focused on developing therapies for neuromuscular disorders.
Dyne Therapeutics, Inc. Common Stock uses the ticker $DYN for trading. Listed in the Stocks category within the Healthcare sectors.
Price 24-Hour Time-Series Raw Data
The stock price is currently influenced by positive clinical trial data and FDA designations, but tempered by valuation concerns, leading to a recent pullback after gains. Social media indicates mixed sentiment with analyst target raises and institutional interest.
24-Hour: -XXXXX% 7-Day: -XXXXX% 30-Day: -XXXX%
1-Year High: $XXXXX on 2024-12-11
1-Year Low: $XXXX on 2025-04-08
AltRank 24-Hour Time-Series Raw Data
Dyne Therapeutics, Inc. Common Stock (DYN) is currently AltRank #150 based on combined combined social and market metrics
Daily Average: XXX
X Week: XXX -XXX
X Month: XXX -XXX
X Months: XXX -XXX
X Year: XXX -XXX
1-Year High: XXXXX on 2025-09-15
1-Year Low: X on 2024-12-28
Galaxy Score 24-Hour Time-Series Raw Data
Current Value: XXXXX
Daily Average: XX
X Week: XX -X
X Month: XX -X
X Months: XX -X
X Year: XX -XX
1-Year High: XX on 2025-12-08
1-Year Low: XX on 2025-12-03
Engagements 24-Hour Time-Series Raw Data
Current Value: XXXXXX
Daily Average: XXXXX
X Week: XXXXXX +432%
X Month: XXXXXXX +23%
X Months: XXXXXXXXX -XX%
X Year: XXXXXXXXX -XX%
1-Year High: XXXXXXX on 2025-04-25
1-Year Low: XXX on 2025-12-06
Engagements by network (24h): Reddit: XX X: XXXXXX YouTube: XX
Mentions 24-Hour Time-Series Raw Data
Current Value: XXX
Daily Average: XXX
X Week: XXX -XX%
X Month: XXX -XX%
X Months: XXXXX +8.30%
X Year: XXXXX +5.70%
1-Year High: XXX on 2025-10-27
1-Year Low: X on 2025-09-14
Mentions by network (24h): Reddit: X X: XXXXX YouTube: X
Creators 24-Hour Time-Series Raw Data
XX unique social accounts have posts mentioning Dyne Therapeutics, Inc. Common Stock (DYN) in the last XX hours which is down XX% from XX in the previous XX hours
Daily Average: XX
X Week: XXX -XX%
X Month: XXX -XX%
X Months: XXXXX +120%
X Year: XXXXX +74%
1-Year High: XXX on 2025-06-28
1-Year Low: X on 2025-09-14
The most influential creators that mention Dyne Therapeutics, Inc. Common Stock in the last XX hours
| Creator | Rank | Followers | Posts | Engagements |
|---|---|---|---|---|
| @adamfeuerstein | X | XXXXXXX | X | XXXXXX |
| @BioStocks | X | XXXXXX | X | XXXXX |
| @semodough | X | XXXXXX | X | XXXXX |
| @RNAiAnalyst | X | XXXXXX | XX | XXXXX |
| @monaco_biotech | X | XXXXX | X | XXX |
| @FrenzyCapital | X | XXXXX | XX | XXX |
| @Hall8Jack | X | XXXXX | X | XXX |
| @bioinvestor24 | X | XXXXX | X | XXX |
| @OzmosiHealth | X | XXXXX | X | XXX |
| @BiotechAnalysst | XX | XXXXX | X | XXX |
Sentiment 24-Hour Time-Series Raw Data
Current Value: XX%
Daily Average: XX%
X Week: XX% -XX%
X Month: XX% +13%
X Months: XX% +8%
X Year: XX% -X%
1-Year High: XXX% on 2025-10-18
1-Year Low: XX% on 2025-01-04
Most Supportive Themes:
Most Critical Themes:
Social Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXX%
Daily Average: XXXXX%
X Week: XXXXX% +0.047%
X Month: XXXXX% +0.042%
X Months: XXXXX% +0.035%
X Year: XXXXX% +0.0064%
1-Year High: XXXXX% on 2025-04-29
1-Year Low: XXXXXX% on 2025-09-14
Market Dominance 24-Hour Time-Series Raw Data
Current Value: XXXXXXX%
Daily Average: X%
1-Year High: XXXXX% on 2025-11-24
1-Year Low: XXXXXXX% on 2025-03-14
Market Cap 24-Hour Time-Series Raw Data
Current Value: $XXXXXXXXXXXXX
Daily Average: $XXXXXXXXXXXXX
X Week: $XXXXXXXXXXXXX -$10%
X Month: $XXXXXXXXXXXXX +$0.76%
X Months: $XXXXXXXXXXXXX +$61%
X Year: $XXXXXXXXXXXXX -$9.40%
1-Year High: $XXXXXXXXXXXXX on 2025-10-28
1-Year Low: $XXXXXXXXXXX on 2025-04-08
Top posts by engagements in the last XX hours
Showing only X posts for non-authenticated requests. Use your API key in requests for full results.
"#Biotech offerings priced - $TERN $650M at $40/share $GPCR $650M at $65/ADS $KYMR $602M at $86/share $WVE $350M at $19/share $DYN $350M at $18.44/share $VERA $261M at $42.50/share $XXXX Billionš„ $XBI"
X Link @BioStocks 2025-12-10T04:47Z 70.4K followers, 5063 engagements
"$DYN Dyne Therapeutics presented P1 Muscular Dystrophy Duchenne results on 2025-12-08 for Zeleciment rostudirsen More Info:"
X Link @OzmosiHealth 2025-12-09T21:21Z 3011 followers, XXX engagements
"Midday Fly By: Nvidia can ship H200s to China Campbell's reports Q1 beat $FERG $VIK $NCLH $CL $VRT $SNPS $SLM $DIS $BAC $C $APO $PSKY $WBD $ACN $CWAN $CPNG $ALEX $TROX $STAA $AA $PHR $CNM $DBI $LE $GIII $DYN $NVDA $HD $CVS $F $RNLSY $RNSDF $CPB"
X Link @theflynews 2025-12-09T17:57Z 28.8K followers, XXX engagements
"Biggest Losers: $FERG $BEKE $SMMT $KYMR $SLM $GPK $KTB $WRD $AAP $DYN $OLMA"
X Link @FrenzyCapital 2025-12-09T16:00Z 1563 followers, XXX engagements
/topic/dyne-therapeutics